Lifestyle Changes in PCOS with OSA and NAFLD

Cairo University40 enrolled

Overview

Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended

Forty obese PCOS men with obstructive sleeping apnea and compaint of fatty liver will participate in this trial . Group (study group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes. Group (control group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver . for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake,

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

PCOS NAFLD OSA

Interventions

diet restriction and exerciseBEHAVIORAL

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes

diet restrictionBEHAVIORAL

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily) and program of low diet intake

Eligibility

Sex: FEMALEMin age: 30 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * forty women * women complaint PCOS * women complain obstructive sleep apnea * women are obese * women complain fatty liver Exclusion Criteria: * cardiac insult * renal insult * malignacy * pregnancy

Locations (2)

faculty of physical therapy Cairo university

Dokki, Giza Governorate, Egypt

RECRUITING

faculty of physical therapy Cairo university

Dokki, Giza Governorate, Egypt

RECRUITING

Outcomes

Primary Outcomes

aspartate transamianse

Time frame: it will be assessed in serum after eight weeks

Secondary Outcomes

alanine transaminase

Time frame: it will be assessed in serum after eight weeks

triglycerides

Time frame: it will be assessed in serum after eight weeks

neck circumference